In March 2025, the company declared new designs for your immediate-to-purchaser offering of its Wegovy weight loss drug. The company established a different pharmacy, called NovoCare, which might demand customers $499 a month for use of the drug, lower than half the expense of the drug by way of other pharmaceutical distribution networks.[53]Rybels